Results 311 to 320 of about 8,509,826 (346)
Some of the next articles are maybe not open access.
Quantitative analysis of placebo response and factors associated with menopausal hot flashes
Menopause, 2017Objective: The aim of the study was to quantitatively analyze the placebo response and the factors associated with menopausal hot flashes. Methods: The PubMed and Cochrane Library databases were searched for placebo-controlled trials that reported the ...
Lujin Li+5 more
semanticscholar +1 more source
Placebo response, placebo effect, and two attributes
Psychopharmacology, 1979Two putative predictors of placebo response were studied in three samples of psychiatric outpatients. Two groups, 73 university medical center patients and 56 college health service patients, underwent 1 week of placebo treatment. A quasi-control group of 112 patients receiving no medication waited about 1 week before beginning psychotherapy.
David Haskell+3 more
openaire +2 more sources
The placebo response in social phobia
Journal of Psychopharmacology, 2001The placebo response forms a growing problem in randomized, placebo-controlled clinical trials in psychiatry. Research into the placebo response is on the increase, but remains very limited in relation to social phobia. Together with the dropout rate, the placebo effect is an important factor limiting the discriminative properties of any study.
Oosterbaan, Désirée B.+3 more
openaire +4 more sources
The nature of placebo response in clinical studies of major depressive disorder.
Journal of Clinical Psychiatry, 2015OBJECTIVE To review factors influencing placebo response and clinical trial outcome in depression, and suggest ways to optimize trial success in mood disorders.
G. Papakostas+2 more
semanticscholar +1 more source
Placebo response correlates with hypnotic suggestibility.
, 2016Placebo response shares phenomenology and likely overlaps with substrates of cognition and personality. However, inconsistent findings abound regarding the potential link between suggestibility and responding to placebos.
E. O. Sheiner, M. Lifshitz, A. Raz
semanticscholar +1 more source
Journal of Analytical Psychology, 2004
Abstract: Placebo effects contribute to beneficial therapeutic responses and are common in anxiety and depressive disorders. It is posited that placebo effects are yielded by autonomous feeling‐toned complexes capable of re‐establishing background self‐states of well‐being.
openaire +3 more sources
Abstract: Placebo effects contribute to beneficial therapeutic responses and are common in anxiety and depressive disorders. It is posited that placebo effects are yielded by autonomous feeling‐toned complexes capable of re‐establishing background self‐states of well‐being.
openaire +3 more sources
Predictors of placebo response in bipolar depression
International Clinical Psychopharmacology, 2015The aim of this work is to investigate placebo response rates in placebo-controlled randomized clinical trials (RCTs) of pharmacological therapy in bipolar depression (BPD) and to identify predictors of placebo response and clinical trial outcome in BPD.
A. Nierenberg+5 more
semanticscholar +1 more source
Increasing placebo response in antipsychotic trials: a clinical perspective
Evidence-Based Mental Health, 2015An increase in placebo response is often cited as rationale for the continuously diminishing drug-placebo differences in randomized controlled trials (RCTs) evaluating antipsychotic and antidepressant drugs. As a consequence, the probability for negative
M. Dold, S. Kasper
semanticscholar +1 more source
Arthritis & Rheumatology, 2019
To evaluate the efficacy, including capacity for inhibition of radiographic progression, and safety of upadacitinib, a JAK1‐selective inhibitor, as compared to placebo or adalimumab in patients with rheumatoid arthritis (RA) who have experienced an ...
R. Fleischmann+11 more
semanticscholar +1 more source
To evaluate the efficacy, including capacity for inhibition of radiographic progression, and safety of upadacitinib, a JAK1‐selective inhibitor, as compared to placebo or adalimumab in patients with rheumatoid arthritis (RA) who have experienced an ...
R. Fleischmann+11 more
semanticscholar +1 more source
BMJ, 2008
If both subjective symptoms and physical signs of a physical disease respond to an inert process or substance, the patient did something that caused the response.1 If patients demonstrate this capacity to self treat, doctors should be asking at …
openaire +3 more sources
If both subjective symptoms and physical signs of a physical disease respond to an inert process or substance, the patient did something that caused the response.1 If patients demonstrate this capacity to self treat, doctors should be asking at …
openaire +3 more sources